Global Meperidine
(Demerol) Market, by Dosage Form (Tablets, Injection, and Syrup), by
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online
Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) is estimated to be valued at US$ 2,089.1 Mn in 2020 and
is expected to increase to US$ 2,784.3 Mn by 2027, witnessing a CAGR of 4.2%
during the forecast period (2020-2027) as highlighted in a new report published
by Coherent Market Insights.
Manufacturers are engaged in
developing new meperidine (Demerol) products for pain management, which has led
to an increase in product launches and approvals. This is expected to boost the
global meperidine (Demerol) market growth. For instance, in 2015, Epic Pharma,
launched generic meperidine in the U.S. for the relief of moderate to severe
pain in 50-mg and 100-mg dosage strengths in 100 count bottles. Moreover,
manufacturers such as Pfizer, Inc., Hikma Pharmaceuticals, and others also
offer branded as well as generic meperidine in the market.
Browse 24 Market Data Tables, and
26 Figures spread through 140 Pages and in-depth TOC on Global Meperidine
(Demerol) Market, by Dosage Form (Tablets, Injection, and Syrup), by
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online
Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) - Global Forecast to 2027
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3816
The rising prevalence of chronic
diseases such as cancer and pain associated diseases is expected to result in
higher use of potent opioid medications for pain management. Moreover,
meperidine is used as a drug for post-operative pain. Meperidine has advantages
such as providing very short analgesia which is appropriate for minimally
invasive surgeries. Moreover, the growing preference for minimally invasive
surgeries is also expected to support growth of the market during the forecast
period. For instance, according a study published in January 2020 in Jama
Network (The Journal of the American Medical Association), the use of robotic
surgeries for all procedures had increased from 1.8% to 15.1% from 2012 to 2018
in the U.S. These factors are expected to support global meperidine (Demerol)
market growth during the forecast period.
The increasing number of surgical
procedures are expected to drive the global meperidine (Demerol) market growth
Opioids such as meperidine are
used as pre-anesthetic medication in the surgical procedure, and are also used
as part of anesthesia to prevent pain after surgical procedure. Opioids are
also used in surgical treatment related to cancer. They are also used in
cardiovascular procedures to obtain the relief from post-surgical treatment
pain. The increasing number of surgeries worldwide is expected to support
growth of the market during the forecast period. For instance, according to Eurostat,
2019, there were at least 1.4 million caesarean sections performed in the EU in
2017. Moreover, pain management related to cancer disease, back pain,
neuropathic pain, migraine, osteoarthritis, and pain which occurs after the
surgical procedures also involves use of opioids such as meperidine. The rising
prevalence of such diseases is expected to support global meperidine (Demerol)
market growth during the forecast period.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/meperidine-market-3816
Key takeaways of the global
meperidine (Demerol) market:
The global meperidine (Demerol)
market is expected to exhibit a CAGR of 4.2% during the forecast period
(2020-2027) owing to product approvals and launches as well as increasing
prevalence of chronic diseases requiring surgical intervention.
On the basis of dosage form, the
injection segment is expected to hold a dominant position in the global
meperidine (Demerol) market during the forecast period owing to high use in
post-operative pain management and post pregnancy pain management.
Based on distribution channel,
the hospital pharmacies segment is expected to witness significant growth due
to increasing use of meperidine in post-operative pain management as it would
be sold through hospital pharmacies.
Some of the major players
involved in the global meperidine (Demerol) market are Pfizer, Inc., Hikma
Pharmaceuticals USA Inc., Epic Pharma, Inc., and Vintage Pharmaceuticals, Inc.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3816
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment